http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5512577-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb13873f6bc564d17413c08320c71c1f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4748 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4748 |
| filingDate | 1994-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1996-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d582e211c7ab707bdd76d7b7fc953f58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fc02baf1aa8de13f5fedb61394ae0d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5ad2727caf3cd78f90fc6dcf043cc82 |
| publicationDate | 1996-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5512577-A |
| titleOfInvention | Bicyclic hexahydroaporphine and 1-benzyloctahydroisoquinoline therapeutic compositions and processes for utilizing said compositions |
| abstract | The invention relates to the method of synthesis of bicyclic hexahydroaporphine compounds which may provide improved therapy for diseases characterized by an increase in intraocular pressure. More specifically, the present invention relates to the preparation of agents which may provide for improved treatment of patients with glaucoma or ocular hypertension. The present invention describes the intraocular pressure lowering capabilities of several of the bicyclic hexahydroaporphine structures. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005059098-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6730691-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005059098-A2 |
| priorityDate | 1994-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 360.